VITASTEMVitaStem
$0.027
$0.0039
(12.72%)
Mkt Cap$86,202.00
Vol413.39
Fundamentals
Mkt Cap
$86,202.00
24H Volume
$413.39
7D High
$0.0424
FDV
$270,074.00
Circ Supply
3.19M
Total Supply
10M
Max Supply
10M
24H High
$0.0315
24H Low
$0.0267
50
Neutral Sentiment
How do you feel about VITASTEM?
<
...
1
>
Bullish/Bearish Forum Sentiment
Indicates whether most users posting on a crypto’s stream over the last 24 hours are bearish or bullish.
0
25
50
75
100
Extremely
Bearish
Neutral
Bullish
Extremely
Bearish
Bullish
N/A
Last score
N/A
1 day ago
Sign Up / Log In
1 week ago
Sign Up / Log In
1 month ago
Sign Up / Log In
3 months ago
Sign Up / Log In
6 months ago
Sign Up / Log In
1 year ago
Sign Up / Log In
Message Board Activity
Measures the total amount of chatter on a stream over the last 24 hours.
0
25
50
75
100
Extremely
Low
Normal
High
Extremely
Low
High
N/A
Last score
N/A
1 day ago
Sign Up / Log In
1 week ago
Sign Up / Log In
1 month ago
Sign Up / Log In
3 months ago
Sign Up / Log In
6 months ago
Sign Up / Log In
1 year ago
Sign Up / Log In
Discussion Diversity
Measures the number of unique accounts posting on a stream relative to the number of total messages on that stream.
0
25
50
75
100
Extremely
Low
Normal
High
Extremely
Low
High
N/A
Last score
N/A
1 day ago
Sign Up / Log In
1 week ago
Sign Up / Log In
1 month ago
Sign Up / Log In
3 months ago
Sign Up / Log In
6 months ago
Sign Up / Log In
1 year ago
Sign Up / Log In
AboutVitaSTEM — The first AI-enabled longevity project and inaugural IP-Token launched by Aubrai, VitaDAO’s decentralized scientific agent. After six months of deep research on public and proprietary single-cell RNA-seq and multi-omics datasets, our scientific research team analyzed more than 850,000 human hematopoietic stem cell transcriptomes from donors aged 23–91 (both male and female). This effort uncovered 100+ high-potential rejuvenation target genes and revealed critical drivers of decline such as RhoA hyperactivation, CD38 upregulation, and CCR9 downregulation. Rather than treating HSC aging as a single defect, Aubrai recognized it as convergent damage across interconnected systems, generating a comprehensive multi-modal, five-phase rejuvenation protocol targeting transcriptional stress, metabolic dysfunction, and epigenetic drift in parallel. The agent shortlisted target genes using insights from thousands of peer-reviewed publications and private data and also optimized experimental protocols to guide in vitro and upcoming pre-clinical testing. For the first time, human researchers and AI Agents collaborate as co-scientists in the creation of pioneering scientific IP.
DetailsCategories
Base EcosystemClanker EcosystemDecentralized Science (DeSci)
Date
Market Cap
Volume
Close
June 05, 2026
$86,202.20
$413.39
---
June 05, 2026
$96,258.21
$579.80
---
June 04, 2026
$111,062.27
$5,806.21
$0.0348
June 03, 2026
$126,589.09
$951.82
$0.0397
June 02, 2026
$120,322.59
$142.55
$0.0377
June 01, 2026
$118,260.52
$181.86
$0.0371
May 31, 2026
$117,939.67
$83.62
$0.037
May 30, 2026
$118,660.12
$205.53
$0.0372
May 29, 2026
$116,907.65
$118.30
$0.0366
May 28, 2026
$121,223.36
$295.14
$0.038